These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8346842)

  • 21. Diffuse rash associated with transdermal fentanyl.
    Stoukides CA; Stegman M
    Clin Pharm; 1992 Mar; 11(3):222. PubMed ID: 1535304
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
    Tawfik MO; Bryuzgin V; Kourteva G;
    Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of transdermal fentanyl on quality of life in rheumatoid arthritis.
    Berliner MN; Giesecke T; Bornhövd KD
    Clin J Pain; 2007; 23(6):530-4. PubMed ID: 17575494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal fentanyl: informed prescribing is essential.
    Ross JR; Quigley C
    Eur J Pain; 2003; 7(5):481-3. PubMed ID: 12935801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comment: transdermal fentanyl.
    Patt RB; Hogan LA
    Ann Pharmacother; 1993 Jun; 27(6):795-6. PubMed ID: 8329811
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tumor pain. Fentanyl TTS: a transdermal system for tumor pain therapy].
    Dtsch Med Wochenschr; 1995 Oct; 120(41 Suppl):1-4. PubMed ID: 9022357
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of cancer pain with transdermal fentanyl.
    Gourlay GK
    Lancet Oncol; 2001 Mar; 2(3):165-72. PubMed ID: 11902567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transdermal fentanyl dependency in the treatment of chronic pain in the elderly: presentation of a case].
    Calle Egusquiza A; Planas Domingo J; Farriols Danés C
    Rev Esp Geriatr Gerontol; 2011; 46(3):179. PubMed ID: 21477893
    [No Abstract]   [Full Text] [Related]  

  • 30. Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain.
    Tani M; Fuku A; Terashita S; Kashiwagi H; Yukawa H; Yamaue H
    Hepatogastroenterology; 2008; 55(86-87):1545-8. PubMed ID: 19102339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy.
    Ripamonti C; Fagnoni E; Campa T; Brunelli C; De Conno F
    Support Care Cancer; 2006 May; 14(5):400-7. PubMed ID: 16485087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Transdermal fentanyl: a new tool for pain therapy in pediatric oncology].
    Cappelli C; Reale G; Marucci G; Clerico A
    Clin Ter; 2008; 159(4):257-60. PubMed ID: 18776983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transdermal fentanyl: caution in the use of high doses.
    Botterman J; De Meester C; Eeckhaut K
    Palliat Med; 2004 Oct; 18(7):663. PubMed ID: 15540677
    [No Abstract]   [Full Text] [Related]  

  • 34. Fentanyl transdermal system: market withdrawal. Exposes patients to a risk of overdose. The market withdrawal, due to a manufacturing defect, is more than welcome.
    Prescrire Int; 2009 Jun; 18(101):110. PubMed ID: 19637419
    [No Abstract]   [Full Text] [Related]  

  • 35. Sticking to the safe side with fentanyl patches.
    D'Arcy Y
    Nursing; 2009 Mar; 39(3):62-3. PubMed ID: 19247136
    [No Abstract]   [Full Text] [Related]  

  • 36. Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics.
    Portenoy RK; Southam MA; Gupta SK; Lapin J; Layman M; Inturrisi CE; Foley KM
    Anesthesiology; 1993 Jan; 78(1):36-43. PubMed ID: 8424569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.
    Payne R; Mathias SD; Pasta DJ; Wanke LA; Williams R; Mahmoud R
    J Clin Oncol; 1998 Apr; 16(4):1588-93. PubMed ID: 9552070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fentanyl transdermal system. Pain management at home.
    Woodroffe MA; Hays H
    Can Fam Physician; 1997 Feb; 43():268-72. PubMed ID: 9040914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.
    Kornick CA; Santiago-Palma J; Moryl N; Payne R; Obbens EA
    Drug Saf; 2003; 26(13):951-73. PubMed ID: 14583070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdermal fentanyl.
    Abidin MR; Arosarena O; Koch WM; Eisele DW
    Otolaryngol Head Neck Surg; 1994 Nov; 111(5):680-3. PubMed ID: 7970812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.